| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of radium-223 therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) as third line therapy
|
Dresler, H.
|
|
|
18 |
11 |
p. e3468
|
artikel
|
| 2 |
Activity of the FGFR1–3 inhibitor infigratinib in patients with upper tract urothelial carcinoma and urothelial carcinoma of the bladder: Latest efficacy findings and comprehensive genomic profiling/cell-free DNA data
|
De Giorgi, U.
|
|
|
18 |
11 |
p. e3405-e3406
|
artikel
|
| 3 |
ADNP-mediated cell cycle promotes bladder cancer cell proliferation via AKT pathway
|
Yu, X.
|
|
|
18 |
11 |
p. e3553
|
artikel
|
| 4 |
Analysis of surgical, oncological and functional outcomes of robot assisted radical prostatectomy in men over 75 years of age
|
Singh, S.
|
|
|
18 |
11 |
p. e3437
|
artikel
|
| 5 |
Analysis on dose adjustment of axitinib for metastatic renal cell carcinoma
|
Kishida, T.
|
|
|
18 |
11 |
p. e3523
|
artikel
|
| 6 |
An outcome analysis of robot-assisted radical nephroureterectomy with extended template lymphadenectomy for upper tract urothelial carcinoma
|
Singh, S.
|
|
|
18 |
11 |
p. e3524-e3526
|
artikel
|
| 7 |
A phase 2 study of the combination of PLK1 inhibitor, onvansertib, with abiraterone and prednisone in patients with metastatic castration-resistant prostate cancer
|
Einstein, D.J.
|
|
|
18 |
11 |
p. e3462
|
artikel
|
| 8 |
Application of Raman spectroscopy coupled with chemometrics to the early diagnostics and classification of prostate cancer
|
Sanchis-Bonet, A.
|
|
|
18 |
11 |
p. e3511-e3512
|
artikel
|
| 9 |
Are multiparametric MRI findings sufficient for proper prostate cancer decision making?: Predictors of false-negatives in a multicentric study
|
Gonçalves Correia, J.R.
|
|
|
18 |
11 |
p. e3428
|
artikel
|
| 10 |
A retrospective analysis of the safety and activity of Lutetium-177-PSMA radionuclide treatment in heavily-pretreated men with metastatic castration-resistant prostate cancer
|
Gadot, M.
|
|
|
18 |
11 |
p. e3473
|
artikel
|
| 11 |
Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate in the initial biopsy setting
|
Maffei, D.
|
|
|
18 |
11 |
p. e3417
|
artikel
|
| 12 |
Association of pre-treatment serum testosterone level with prostate cancer: Study in north western population of India
|
Bora, G.S.
|
|
|
18 |
11 |
p. e3513
|
artikel
|
| 13 |
A two-gene methylation signature for the diagnosis of bladder cancer in urine
|
Bosschieter, J.
|
|
|
18 |
11 |
p. e3562
|
artikel
|
| 14 |
Autological fat stromal-vascular fraction injection for the treatment of stress urinary incontinence in men who underwent radical prostatectomy
|
Maksimova, S.
|
|
|
18 |
11 |
p. e3456
|
artikel
|
| 15 |
Biology of telomeres in prostate cancer: Development of new risk models
|
Rubio Galisteo, J.M.
|
|
|
18 |
11 |
p. e3426
|
artikel
|
| 16 |
Bladder cancer new biomarkers in liquid biopsies
|
Falcao, G.
|
|
|
18 |
11 |
p. e3563-e3564
|
artikel
|
| 17 |
Checkpoint inhibitor immune-related adverse events as a prognosis factor in urothelial cancer: A retrospective analysis
|
Parmanande, A.Q.
|
|
|
18 |
11 |
p. e3608
|
artikel
|
| 18 |
Clinical and pathologic characteristics of familial prostate cancer in Asian population
|
Byun, S-S.
|
|
|
18 |
11 |
p. e3490
|
artikel
|
| 19 |
Clinical outcome after radical metastasectomy in renal cell carcinoma: Results from a randomized phase 2 study
|
Procopio, G.
|
|
|
18 |
11 |
p. e3552
|
artikel
|
| 20 |
Clinical outcomes of patients with metastatic renal cell carcinoma receiving subsequent therapy after progression on front-line immune-VEGF TKI combination therapy
|
Szabados, B.
|
|
|
18 |
11 |
p. e3529
|
artikel
|
| 21 |
Clinical outcomes of robot-assisted laparoscopic partial nephrectomy: Lessons learnt from 221 cases
|
Bora, G.S.
|
|
|
18 |
11 |
p. e3528
|
artikel
|
| 22 |
Clinical utility of PSMA PET in biochemically recurrent prostate cancer: A systematic review and meta-analysis
|
Perera, M.
|
|
|
18 |
11 |
p. e3497
|
artikel
|
| 23 |
Cognitive function in patients undergoing radical prostatectomy
|
Brzoszczyk, B.
|
|
|
18 |
11 |
p. e3453
|
artikel
|
| 24 |
Combination of urinary symptoms & cytology can decrease the need of cystoscopies at regular follow-up assessments for post triple modality bladder preservation treatment in MIBC
|
Krishnatry, R.
|
|
|
18 |
11 |
p. e3593-e3594
|
artikel
|
| 25 |
Comparative study of prophylactic tadalafil or tamsulosin in patients treated wth low dose rate brachytherapy for prostate cancer
|
Mizuno, R.
|
|
|
18 |
11 |
p. e3455
|
artikel
|
| 26 |
Comparing the detection rates of prostate cancer with variable PSA density cut off on transperineal template biopsies of prostate regardless of mpMRI findings
|
Awan, M.T.
|
|
|
18 |
11 |
p. e3504-e3505
|
artikel
|
| 27 |
Comparison by Pentafecta criteria of transperitoneal and retroperitoneal robotic partial nephrectomy for large renal tumors
|
Choi, C.
|
|
|
18 |
11 |
p. e3522
|
artikel
|
| 28 |
Comparison of cancer detection rates in micro-ultrasound biopsies versus robotic ultrasound-magnetic resonance imaging fusion biopsies for prostate cancer
|
Rojas Claros, O.
|
|
|
18 |
11 |
p. e3503
|
artikel
|
| 29 |
Complications of laser fulguration in an ambulatory circuit versus transurethral bladder resection in nonmuscle invasive cancer
|
Mazuecos Quiros, J.
|
|
|
18 |
11 |
p. e3566
|
artikel
|
| 30 |
Could previous intravesical device-assisted therapy compromise morbidity related to radical cystectomy?
|
Racioppi, M.
|
|
|
18 |
11 |
p. e3592
|
artikel
|
| 31 |
CRP at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma
|
Noguchi, G.
|
|
|
18 |
11 |
p. e3538-e3539
|
artikel
|
| 32 |
Cytoreductive nephrectomy in metastatic renal cell carcinoma: Outcomes of patients treated with a multidisciplinary algorithm-driven approach
|
Liu, W.K.
|
|
|
18 |
11 |
p. e3520-e3521
|
artikel
|
| 33 |
Cytoreductive radical prostatectomy with hormonal therapy: Benefit in cancer-specific survival
|
Styopushkin, S.
|
|
|
18 |
11 |
p. e3463
|
artikel
|
| 34 |
Development of a machine learning algorithm to accurately detect clinically significant prostate cancer on MRI
|
Dillon, J.W.M.
|
|
|
18 |
11 |
p. e3493
|
artikel
|
| 35 |
Diagnostic non-invasive biopsy can substitute conventional tissue dependent procedures in suspected cases of renal cell carcinoma
|
Akolkar, D.
|
|
|
18 |
11 |
p. e3515
|
artikel
|
| 36 |
Diagnostic performance and impact on management intent of 18F-PSMA-1007 PET/CT in newly diagnosed high-risk prostate cancer
|
Rautio, A.
|
|
|
18 |
11 |
p. e3457
|
artikel
|
| 37 |
Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer
|
Maffei, D.
|
|
|
18 |
11 |
p. e3419
|
artikel
|
| 38 |
Discovery of prognostic biomarkers from the prostate cancer membrane proteome using bioorthogonal chemistry
|
Asante-Asare, L.
|
|
|
18 |
11 |
p. e3479
|
artikel
|
| 39 |
Do emergency department physicians understand immunotherapy?: Survey in the largest London University Hospital Trust
|
Butters, T.
|
|
|
18 |
11 |
p. e3577
|
artikel
|
| 40 |
Does curative treatment decrease mortality in senior adults with high-risk prostate cancer (PCa)?
|
Aas, K.
|
|
|
18 |
11 |
p. e3440
|
artikel
|
| 41 |
Early hyperbaric oxygen therapy improves radiation induced hemorrhagic cystitis and proctitis
|
Takeda, H.
|
|
|
18 |
11 |
p. e3507
|
artikel
|
| 42 |
Editorial Board
|
|
|
|
18 |
11 |
p. i-ii
|
artikel
|
| 43 |
Effectiveness of abiraterone acetate in elderly chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
|
Abreu, S.
|
|
|
18 |
11 |
p. e3471
|
artikel
|
| 44 |
Effectiveness of abiraterone acetate in elderly patients with metastatic castration-resistant prostate cancer after docetaxel-based chemotherapy
|
Abreu, S.
|
|
|
18 |
11 |
p. e3470
|
artikel
|
| 45 |
Effect of testicular dysgenesis syndrome on testicular germ cell tumor prognosis and oncological outcomes
|
Selvi, I.
|
|
|
18 |
11 |
p. e3610-e3613
|
artikel
|
| 46 |
Efficacy of perioperative chemotherapy for patients with histological variants in urothelial carcinoma of the bladder
|
Minato, A.
|
|
|
18 |
11 |
p. e3570-e3571
|
artikel
|
| 47 |
Enzalutamide in castration-resistant metastatic prostate cancer treatment, an Oporto’s center experience
|
Reis, J.
|
|
|
18 |
11 |
p. e3459
|
artikel
|
| 48 |
Enzalutamide in metastatic castration-resistant prostate cancer after chemotherapy: Real-world data
|
Castro Oliveira, L.
|
|
|
18 |
11 |
p. e3472
|
artikel
|
| 49 |
Enzalutamide in metastatic castration resistant prostate cancer before chemotherapy
|
Ferreia Pereira, F.
|
|
|
18 |
11 |
p. e3469
|
artikel
|
| 50 |
Evolving landscape of nephron sparing surgery: National Registry data in Australia between 2006 and 2016
|
Perera, M.
|
|
|
18 |
11 |
p. e3527
|
artikel
|
| 51 |
Explaining socio-economic differences in bladder cancer survival
|
Russell, B.
|
|
|
18 |
11 |
p. e3581
|
artikel
|
| 52 |
Favourable and reliable PSA doubling time can improve confidence in reducing the number of repeat biopsy during active surveillance
|
Badenchini, F.
|
|
|
18 |
11 |
p. e3508
|
artikel
|
| 53 |
Feasibility of biparametric magnetic resonance imaging (MRI) based prostate cancer screening compared to conventional method in men without prior biopsies, retrospective comparative study
|
Park, K.K.
|
|
|
18 |
11 |
p. e3423-e3424
|
artikel
|
| 54 |
Follow up of low-risk bladder transitional cell carcinoma (TCC): Is it safe to discharge patients after 12 months of cystoscopic surveillance as recommended by the National Institute of Health and care Excellence, United Kingdom (NICE) guidelines
|
Alsawi, M.
|
|
|
18 |
11 |
p. e3597
|
artikel
|
| 55 |
Fuhrman grade significantly correlated with overall dysfunction of tumor tissue infiltrating lymphocytes and the prognosis of nivolumab treatment
|
Kawashima, A.
|
|
|
18 |
11 |
p. e3540
|
artikel
|
| 56 |
Genomic analysis of localized high-risk prostate cancer identifies XPO1 as a potential driver mechanism of metastatic progression
|
Moris, L.
|
|
|
18 |
11 |
p. e3514
|
artikel
|
| 57 |
Harnessing the patient voice in prostate cancer research: Using patient-reported outcomes in randomized controlled trials to support clinical decision-making
|
Van Hemelrijck, M.
|
|
|
18 |
11 |
p. e3494
|
artikel
|
| 58 |
How to obtain a personalised 3D model of renal cell cancer with venous thrombus extension for surgical planning and simulation?
|
Rivero Belenchón, I.
|
|
|
18 |
11 |
p. e3554-e3555
|
artikel
|
| 59 |
Identification of CCR8 as a specific marker of tumor tissue-infiltrating regulatory T cells and its possibility as a therapeutic target in renal cell carcinoma
|
Kawashima, A.
|
|
|
18 |
11 |
p. e3557
|
artikel
|
| 60 |
Image guided radiotherapy with fiducials in low and intermediate prostate cancer. Outcomes a six years
|
Salas, M.C.
|
|
|
18 |
11 |
p. e3436
|
artikel
|
| 61 |
Impact of MR-guided stereotactic radiotherapy on quality of life of prostate cancer patients
|
Tetar, S.U.
|
|
|
18 |
11 |
p. e3451-e3452
|
artikel
|
| 62 |
Important barriers and facilitators for involving patients in guideline development and implementation for genitourinary cancers
|
Bjorkqvist, J.E.
|
|
|
18 |
11 |
p. e3509
|
artikel
|
| 63 |
Improving IMDC prognostic prediction through evaluation of primary site of metastases in metastatic renal cell carcinoma
|
Mollica, V.
|
|
|
18 |
11 |
p. e3541-e3543
|
artikel
|
| 64 |
Influence of micro-ultrasound guidance on Gleason group upgrading after radical prostatectomy: A retrospective multicenter comparison
|
Ploussard, G.
|
|
|
18 |
11 |
p. e3500
|
artikel
|
| 65 |
Initial angiogenic response in reduced renal mass after transplantation
|
Wilasrusmee, C.
|
|
|
18 |
11 |
p. e3556
|
artikel
|
| 66 |
Initial results comparing high resolution micro-ultrasound with multiparametric magnetic resonance imaging for prostate cancer detection
|
Perez, T.V.R.
|
|
|
18 |
11 |
p. e3499
|
artikel
|
| 67 |
Intraprostatic injection of Liproca® Depot (2-hydroxy flutamide) in patient with localised prostate cancer
|
Klotz, L.H.
|
|
|
18 |
11 |
p. e3620
|
artikel
|
| 68 |
Is the occurrence of higher adverse effects associated with better oncological outcome in Japanese metastatic urothelial carcinoma patients treated with pembrolizumab?
|
Hayakawa, N.
|
|
|
18 |
11 |
p. e3567
|
artikel
|
| 69 |
Laparoscopic partial nephrectomy: 15 years of experience
|
Kalpinskiy, A.
|
|
|
18 |
11 |
p. e3536
|
artikel
|
| 70 |
Lipid cell change of urothelial carcinoma is a sign of tumor aggressiveness and worst prognosis
|
Hayashi, T.
|
|
|
18 |
11 |
p. e3583
|
artikel
|
| 71 |
Long term effect of PectaSol-C modified citrus pectin treatment in non-metastatic biochemically relapsed prostate cancer patients: Results of a prospective phase II study
|
Dresler, H.
|
|
|
18 |
11 |
p. e3467
|
artikel
|
| 72 |
Lumbar skeletal muscle index (sarcopenia) cannot predict early postoperative complications in patients undergoing radical cystectomy for urothelial carcinoma bladder
|
Mavuduru, R.S.
|
|
|
18 |
11 |
p. e3605
|
artikel
|
| 73 |
Metabolic effects in men undergoing androgen deprivation treatment for prostate cancer
|
Cakici, M.C.
|
|
|
18 |
11 |
p. e3475-e3476
|
artikel
|
| 74 |
MicroRNA expression pattern as prognostic marker in upper tract urothelial carcinoma (UTUC)
|
Alvarez Rodríguez, S.
|
|
|
18 |
11 |
p. e3604
|
artikel
|
| 75 |
Micro-ultrasound target biopsies for the diagnosis of clinically significant prostate cancer: Results from a large single-center experience
|
Paciotti, M.
|
|
|
18 |
11 |
p. e3418
|
artikel
|
| 76 |
Micro-ultrasound versus multiparametric MRI in the detection of prostate cancer: Results from a prospective single center trial
|
Maffei, D.
|
|
|
18 |
11 |
p. e3410
|
artikel
|
| 77 |
MR-targeted high frequency TRUS guided biopsies: An alternative to fusion biopsy?
|
Cornud, F.
|
|
|
18 |
11 |
p. e3427
|
artikel
|
| 78 |
Multimodal chemo-hormonal-radiation treatment with use of high-dose-rate brachytherapy with Ir192 of localized high- or very-high-risk or locally advanced prostate cancer
|
Troyanov, A.
|
|
|
18 |
11 |
p. e3432-e3433
|
artikel
|
| 79 |
Multi-parametric MRI performance using PI-RADS v2 in detecting clinically significant prostate cancer after negative biopsy and persisting suspicion of malignancy
|
Kincius, M.
|
|
|
18 |
11 |
p. e3416
|
artikel
|
| 80 |
Multiparametric MRI to detect prostate cancer: Should we use other risk assessments for patient selection?
|
Gonçalves Correia, J.R.
|
|
|
18 |
11 |
p. e3429
|
artikel
|
| 81 |
Neoadjuvant chemotherapy influence on post-surgical complications after radical cystectomy
|
Sanchez Guerrero, C.
|
|
|
18 |
11 |
p. e3595-e3596
|
artikel
|
| 82 |
Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and its impact on surgical morbidity: Real life experience
|
Jeronimo Alves, L.
|
|
|
18 |
11 |
p. e3578
|
artikel
|
| 83 |
New method of formation of vesico-urethral anastomosis during radical prostatectomy
|
Nyushko, K.M.
|
|
|
18 |
11 |
p. e3431
|
artikel
|
| 84 |
Nivolumab in metastatic renal cell carcinoma (mRCC) patients with chronic hepatitis C virus (HCV) infection
|
Tsimafeyeu, I.
|
|
|
18 |
11 |
p. e3518-e3519
|
artikel
|
| 85 |
Non-clear cell renal cell carcinoma: 25 years of surgical experience
|
Alekseev, B.
|
|
|
18 |
11 |
p. e3545
|
artikel
|
| 86 |
Office- based Ho-YAG laser vaporization of small recurrences of non-muscle invasive bladder cancer (NMIBC): Results and costs
|
Sanchez Gonzalez, A.
|
|
|
18 |
11 |
p. e3579-e3580
|
artikel
|
| 87 |
Oncological and functional outcomes after radical prostatectomy in obese patients. Prognostic factors of survival
|
Nyushko, K.M.
|
|
|
18 |
11 |
p. e3441
|
artikel
|
| 88 |
Oncological control in high-risk prostate cancer after radical prostatectomy and salvage radiotherapy compared to radiotherapy plus primary hormone therapy
|
Cano Velasco, J.
|
|
|
18 |
11 |
p. e3442-e3443
|
artikel
|
| 89 |
Oncological prognostic factors in intermediate risk prostate cancer after laparoscopic radical prostatectomy: 15 years of experience
|
Quesada Olarte, J.M.E.
|
|
|
18 |
11 |
p. e3444-e3445
|
artikel
|
| 90 |
Osteoporosis: Is it really a side effect of ADT?
|
Ku, J.Y.
|
|
|
18 |
11 |
p. e3446-e3448
|
artikel
|
| 91 |
Outcome of patients with metastatic urothelial cancer treated with chemotherapy following immune checkpoint inhibition
|
Grant, M.
|
|
|
18 |
11 |
p. e3573
|
artikel
|
| 92 |
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019?
|
Hentschel, A.E.
|
|
|
18 |
11 |
p. e3559-e3561
|
artikel
|
| 93 |
Partial nephrectomy in solitary kidney tumors
|
Alekseev, B.Y.
|
|
|
18 |
11 |
p. e3532
|
artikel
|
| 94 |
Patient-reported outcomes (PROs) From TITAN: A phase 3, randomized, double-blind study of apalutamide (APA) versus placebo (PBO) added to androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC)
|
Agarwal, N.
|
|
|
18 |
11 |
p. e3413-e3414
|
artikel
|
| 95 |
PIONEER’s systematic review of outcomes reported in effectiveness trials for interventions in locally advanced prostate cancer
|
Beyer, K.
|
|
|
18 |
11 |
p. e3485-e3486
|
artikel
|
| 96 |
PIONEER’s update and integration of a localised prostate cancer core outcome set for effectiveness trials and a standard set for clinical practice
|
Beyer, K.
|
|
|
18 |
11 |
p. e3483-e3484
|
artikel
|
| 97 |
Possibilities of the use of raman-spectroscopy in the diagnostics of in-vitro urinary bladder cancer
|
Pavlov, V.N.
|
|
|
18 |
11 |
p. e3607
|
artikel
|
| 98 |
Pre-biopsy predictors of prostate cancer in the image-fusion non-targeted systematic areas
|
Tosco, L.
|
|
|
18 |
11 |
p. e3425
|
artikel
|
| 99 |
Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting
|
Omrcen, T.
|
|
|
18 |
11 |
p. e3491-e3492
|
artikel
|
| 100 |
Preliminary Results for The Bladder microUS vs. MRI cancer imaging Staging Study: The BUS-MISS
|
Diana, P.
|
|
|
18 |
11 |
p. e3565
|
artikel
|
| 101 |
Primary neuroendocrine tumor of the testis: A rare case report
|
Sousa Castro, A.
|
|
|
18 |
11 |
p. e3615
|
artikel
|
| 102 |
Prognosis and survival in testicular cancer – 10 years in review, a population-based analysis
|
Peixoto, M.
|
|
|
18 |
11 |
p. e3614
|
artikel
|
| 103 |
Prognostic factors after robotic extended radical prostatectomy in patients with locally advanced prostate cancer
|
Miura, N.
|
|
|
18 |
11 |
p. e3458
|
artikel
|
| 104 |
Prognostic factors for intravesical recurrence after nephroureterectomy for urinary tract urothelial carcinoma
|
Jang, C.
|
|
|
18 |
11 |
p. e3584-e3587
|
artikel
|
| 105 |
Prognostic significance of immunohistochemical and pathological factors for early recurrence of localized prostate cancer
|
Bova, P.
|
|
|
18 |
11 |
p. e3480
|
artikel
|
| 106 |
Progression-free survival in high risk non-muscle invasive bladder cancer treated with second-line device assisted therapy: A long follow-up experience
|
Racioppi, M.
|
|
|
18 |
11 |
p. e3569
|
artikel
|
| 107 |
Prospective randomized comparison of quality of life and sexual function between ileal neobladder versus sigmoid neobladder reconstruction following nerve sparing, vas sparing, seminal vesicle sparing and partial prostate sparing radical cystectomy
|
Singh, V.
|
|
|
18 |
11 |
p. e3600
|
artikel
|
| 108 |
Prostate and seminal vesicles sparing cystectomy
|
Castiñerias Fernández, J.
|
|
|
18 |
11 |
p. e3601
|
artikel
|
| 109 |
Prostate biopsy using micro-ultrasound and fusion biopsy of the prostate: True precision?
|
Wiemer, L.
|
|
|
18 |
11 |
p. e3501
|
artikel
|
| 110 |
Proteome-based classification of non-muscle invasive bladder cancer
|
Fragkoulis, C.
|
|
|
18 |
11 |
p. e3407
|
artikel
|
| 111 |
Quality control in the care and treatment of our patients undergoing androgen deprivation therapy
|
González Cáliz, C.
|
|
|
18 |
11 |
p. e3510
|
artikel
|
| 112 |
Quality of life (QL) in metastatic castration resistant prostate cancer (mCRPC) treated in first line with new antiandrogens (NA)
|
Rivero Belenchón, I.
|
|
|
18 |
11 |
p. e3477-e3478
|
artikel
|
| 113 |
Real-time micro-ultrasound guiding of systematic prostate biopsies: Preliminary results from a single-institutional experience
|
Paciotti, M.
|
|
|
18 |
11 |
p. e3421-e3422
|
artikel
|
| 114 |
Real-world outcomes with abiraterone in metastatic castration-resistant prostate cancer: The Prostate Cancer Registry
|
Bjartell, A.S.
|
|
|
18 |
11 |
p. e3465-e3466
|
artikel
|
| 115 |
Reduced BCG dose for treatment patients with non-muscle invasive bladder cancer: 1000 patients single center experience
|
Solovov, V.A.
|
|
|
18 |
11 |
p. e3574
|
artikel
|
| 116 |
Relative telomere length is associated with mortality in prostate cancer patients
|
Langsenlehner, T.
|
|
|
18 |
11 |
p. e3488
|
artikel
|
| 117 |
Risk model- recurrence risk groups for patients with localised renal cell carcinoma
|
Polanco Pujol, L.
|
|
|
18 |
11 |
p. e3550-e3551
|
artikel
|
| 118 |
Role of magnetic resonance in the initial management of patients in active surveillance; predictor of change to active treatment
|
Salguero Segura, J.
|
|
|
18 |
11 |
p. e3438
|
artikel
|
| 119 |
Role of PI-RADS version 2 for prediction of incidental prostate cancer after radical cystoprostatectomy
|
Choo, S.H.
|
|
|
18 |
11 |
p. e3415
|
artikel
|
| 120 |
Safety of abiraterone and enzalutamide in prostate cancer patients treated with anticoagulants
|
Goena Vives, M.C.
|
|
|
18 |
11 |
p. e3411-e3412
|
artikel
|
| 121 |
Stereotactic body radiation therapy using Cyber-Knife in the treatment of patients with localized prostate cancer
|
Ishemgulov, R.
|
|
|
18 |
11 |
p. e3439
|
artikel
|
| 122 |
Study on immune response to intravesical Bacillus Calmette Guerine in non-muscle invasive bladder cancer
|
Mavuduru, R.S.
|
|
|
18 |
11 |
p. e3606
|
artikel
|
| 123 |
Surgical injuries and additional procedures during retroperitoneal lymph node dissection for testis cancer. Ten years experience in a cancer center
|
Preciado Estrella, D.A.
|
|
|
18 |
11 |
p. e3616
|
artikel
|
| 124 |
Surgical management and outcomes of von Hippel-Lindau disease associated renal cell carcinoma: A single institution experience according to the 2 cm rule
|
Osaka, K.
|
|
|
18 |
11 |
p. e3533-e3534
|
artikel
|
| 125 |
Surgical treatment of renal cell carcinoma (RCC) with extended inferior vena cava (IVC) thrombosis: Oncological outcomes
|
Atduev, V.
|
|
|
18 |
11 |
p. e3530
|
artikel
|
| 126 |
Surgical treatment of very high risk prostate cancer patients: Long term outcomes in single institution experience
|
Nyushko, K.M.
|
|
|
18 |
11 |
p. e3430
|
artikel
|
| 127 |
Switch from prednisone to dexamethasone in patients with metastatic castration resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) in a multicenter study
|
Rivero Belenchón, I.
|
|
|
18 |
11 |
p. e3464
|
artikel
|
| 128 |
Systemic anti cancer treatment for penile cancer: Real world experience of tertiary cancer centre
|
Derby, S.
|
|
|
18 |
11 |
p. e3617
|
artikel
|
| 129 |
Systemic treatment for metastatic hormone sensitive prostate cancer: A comprehensive meta-analysis evaluating efficacy, safety and specific sub-groups
|
Di Nunno, V.
|
|
|
18 |
11 |
p. e3495-e3496
|
artikel
|
| 130 |
The cumulative incidence and risk factor of postoperative inguinal hernia in patient undergone radical prostatectomy
|
Ku, J.Y.
|
|
|
18 |
11 |
p. e3449-e3450
|
artikel
|
| 131 |
The current evidence for factors that influence patients’ choice of treatment in stage I kidney cancer: A systematic review
|
Beyer, K.
|
|
|
18 |
11 |
p. e3558
|
artikel
|
| 132 |
The durability of complete response and partial response in patients with genitourinary cancer treated with PD-1/PD-L1 inhibitors
|
Hwang, I.
|
|
|
18 |
11 |
p. e3544
|
artikel
|
| 133 |
The effect of checkpoint inhibitor (CPI) on primary renal cell carcinoma (RCC)
|
Im, H-S.
|
|
|
18 |
11 |
p. e3535
|
artikel
|
| 134 |
The effect of Leuprolide versus Goserelin for volume reduction and lower urinary tract symptoms and voiding relief in prostatic cancer patients
|
Yıkılmaz, T.N.
|
|
|
18 |
11 |
p. e3474
|
artikel
|
| 135 |
The effect of metastatic focus on oncologic outcomes in renal cell carcinoma
|
Selvi, I.
|
|
|
18 |
11 |
p. e3546-e3549
|
artikel
|
| 136 |
The effects of uro-oncology nursing education on the need for out-of-home care after radical cystectomy
|
Selvi, I.
|
|
|
18 |
11 |
p. e3599-e3600
|
artikel
|
| 137 |
The expression and prognostic value of programmed death-ligand 1 in prostate needle biopsy tissue of prostate cancer patients undergoing primary radiation therapy
|
Shim, K.H.
|
|
|
18 |
11 |
p. e3506
|
artikel
|
| 138 |
The gender-specific urinary and bladder tissue microbiome in therapy-naive bladder cancer patients
|
Pederzoli, F.
|
|
|
18 |
11 |
p. e3603
|
artikel
|
| 139 |
The impact of the global BCG shortage on treatment patterns: Australian population-based data
|
Perera, M.
|
|
|
18 |
11 |
p. e3572
|
artikel
|
| 140 |
The past, present, and future of prostate cancer incidence, mortality and prevalence in Denmark during 2006 through 2030
|
Borre, M.
|
|
|
18 |
11 |
p. e3481-e3482
|
artikel
|
| 141 |
The Phoenix criteria for biochemically recurrent prostate cancer after curative radiotherapy appear obsolete in the era of prostate-specific membrane antigen PET: A plea for urgent re-evaluation of current guidelines
|
Jansen, B.H.E.
|
|
|
18 |
11 |
p. e3408-e3409
|
artikel
|
| 142 |
The prognostic value of preoperative neutrophil-to-lymphocyte ratio in patients with upper tract urothelial carcinoma
|
Benmohamed, B.
|
|
|
18 |
11 |
p. e3582
|
artikel
|
| 143 |
The psychological impact of early prostate cancer: A prospective evaluation
|
Dresler, H.
|
|
|
18 |
11 |
p. e3454
|
artikel
|
| 144 |
The role of device assisted techniques in BCG non-responder non-muscle invasive bladder cancer
|
Racioppi, M.
|
|
|
18 |
11 |
p. e3568
|
artikel
|
| 145 |
The role of neutrophil to lymphocyte ratio as a complementary tool in testicular cancer diagnostis
|
Bauza Quetglas, J.L.
|
|
|
18 |
11 |
p. e3609
|
artikel
|
| 146 |
The role of pelvic lymphadenctomy with radical prostatectomy: National registry database analysis assessing patterns of practice
|
Roberts, M.
|
|
|
18 |
11 |
p. e3498
|
artikel
|
| 147 |
The subgroup analysis of intermediate-risk non-muscle invasive bladder cancer: Its effects on recurrence rates and intravesical treatment strategy
|
Selvi, I.
|
|
|
18 |
11 |
p. e3588-e3591
|
artikel
|
| 148 |
The use of Tweak-Fn14 as a non-invasive biomarker panel for prostate cancer
|
Alves Santiago, M.
|
|
|
18 |
11 |
p. e3489
|
artikel
|
| 149 |
The utility of 29 MHz high resolution micro-ultrasound and mpMRI in the management of Gleason six prostate cancer with active surveillance
|
Staerman, F.
|
|
|
18 |
11 |
p. e3502
|
artikel
|
| 150 |
Three-dimensional printing models in bladder radical cystectomy: A valuable tool for surgical training and education
|
Yu, X.
|
|
|
18 |
11 |
p. e3602
|
artikel
|
| 151 |
Timing of radiotherapy (RT) after radical prostatectomy (RP): First results from RADICALS RT randomised controlled trial [NCT00541047]
|
Parker, C.
|
|
|
18 |
11 |
p. e3618-e3619
|
artikel
|
| 152 |
Transcriptional regulation of RNAs in androgen receptor axis by apigenin compared to cabazitaxel efficiency in prostate cancer cells
|
Eryilmaz, I.E.
|
|
|
18 |
11 |
p. e3487
|
artikel
|
| 153 |
Treatment options in metastatic renal cell carcinoma (mRCC): Real-world data from a single institution review
|
Spencer, A.
|
|
|
18 |
11 |
p. e3537
|
artikel
|
| 154 |
Treatment outcomes and survival of metastatic non-clear cell renal cell carcinoma: A single center real-world experience
|
Lopes, A.R.
|
|
|
18 |
11 |
p. e3531
|
artikel
|
| 155 |
Types of pathological progression within Spanish Register on Active Surveillance and their relevance in radical prostatectomy specimens
|
Rubio Briones, J.
|
|
|
18 |
11 |
p. e3434-e3435
|
artikel
|
| 156 |
Ultrasound guided focal brachytherapy in local recurrent prostate cancer after prior radiation treatment
|
in t Ven, L.M.
|
|
|
18 |
11 |
p. e3460-e3461
|
artikel
|
| 157 |
Use of nephrometry score systems in nephron sparing surgery: Applicability and reproducibility from residents perspective
|
Galosi, A.B.
|
|
|
18 |
11 |
p. e3516-e3517
|
artikel
|
| 158 |
Utility of Prostate Health Index and Prostate Health Index Density in predicting detection of clinically significant prostate cancer in a cohort of patients with PSA in the grey zone and normal digital rectal examination
|
Sanchis-Bonet, A.
|
|
|
18 |
11 |
p. e3420
|
artikel
|
| 159 |
Vinflunine (VFL) treatment following induction chemotherapy with platinum combinations in patients with metastatic-advanced urothelial cancer. A single institution experience
|
Martinez Barroso, K.
|
|
|
18 |
11 |
p. e3575-e3576
|
artikel
|
Tijdschrift beschrijving